NCT02863055 2025-09-19
NEMO
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Terminated
Clinical Trials
11 trialsNCT01486368 2023-08-04
A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
Canadian Cancer Trials Group
Phase 2 Completed
NCT00101283 2023-07-03
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT02436733 2022-11-07
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown
NCT00770120 2020-03-06
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
SWOG Cancer Research Network
Phase 2 Completed
NCT00458913 2018-07-12
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00513877 2014-12-31
Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
Cancer Trials Ireland
Phase 2 Completed
NCT00003723 2012-10-08
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
SWOG Cancer Research Network
Phase 2 Completed
NCT00004254 2012-07-18
Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00004920 2012-07-18
Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00227630 2012-07-18
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed